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Cholesterol was linked to 2'-O-methyI-oIigoriboiniucIeo-
tides (2'-QMe-RNA) via a disulfide bond by reacting the
3'-(pyridyldfthio)-modified 2'-OMe-RNA with thio-
cholesterol in dichloramethane-methamol solution. This
ligation reaction was made possible by a novel strategy
in which the highly charged oligonudeotide was
rendered soluble in nonaqueous solvent through
conversion to a lipophilic amidinium salt. The bio-
degradable lipophilic modification of 2'-OMe-RNA
resulted in a large increase in incorporation of such
oligonucleotides into liposomes prepared by reverse-
phase evaporation. Furthermore, association of these
modified oOigonucDeotides with cultured TIB 73 cells
was 100-foOd higher than that seen with unmodified
2'-OMe-RNA in serum-free medium and about 110 to
30-fold higher in the presence of 110% calf serum.
During incubation with cells, release of the internalized
oligonudeotide from the thiocholesteryl moiety can be
demonstrated.
INTRODUCTION
Modified antisense oligonucleotides (ONs) may become important
tools for the study of regulation and inhibition of genes (1,2).
A substantial limitation of this approach is the inefficient uptake
of natural ONs into cells. To enhance the penetration of ONs
into cells, non-ionic methylphosphonate (3), phosphoramidate (4)
analogs or ONs conjugated to poly(L-lysine) (5) have been
designed. A further approach has been to use antibody-targeted
liposomes containing antisense ONs (6) that allow cell-specific
delivery by endocytosis. This interesting method may be
particularly applicable if the encapsulation efficiency of the ONs
(about 3%) could be substantially improved. With this aim, we
considered the use of lipid-modified ONs for incorporation into
liposomes. ONs covalently linked to phospholipid (7), cholesterol
(8,9), dodecandiol (10) or undecyl residues (11) have already
been described and all show an enhanced association with cultured
cells. Permanent trapping of such ON analogs in membranes,
however, may limit their action as antisense compounds. In the
present communication we describe the synthesis of ON-
thiocholesterol conjugates containing a potentially bioreversible
disulfide linkage (12), the highly efficient incorporation of such
compounds into liposomes, as well as their enhanced affinity for
and internalization into cells.
MATERIALS AND METHODS
Quantitative assays
Oligonucleotides were quantified by UV absorbance at 260 nm;
correction of the values (if necessary) was made by subtracting
the corresponding UV absorption of dithiopyridine or buffer at
260 nm. The amount of dithiopyridine linkers in modified ONs
was determined by reducing an aliquot with dithiothreitol and
measuring the absorption of released pyridine-2-thione at 343 nm
(molar extinction coefficient e = 8080 M^'cm"1)- The amount
of PMDBD (Heinzer base, Fluka) was determined by UV
absorption at 219 nm; 1 jtmol of the hydrochloride in water
corresponds to 16.3 AU2i9 (i.e. e= 16300 M-'cm"1)-
Synthesis of S'-amino-modiifned 2'-O-meflhiyl-oligoribo-
mucleotides
The 19mer 2'-O-methylated oligoribonucleotides modified with
(3-amino-2-hydroxypropyl)phosphate at the 3'-end were
synthesized on an ABI 380 B DNA synthesizer (Applied
Biosystems) using a modified LCAA controlled-pore glass (CPG)
solid support carrying l-O-DMTr,3-N-[fluorenyl(methoxy-
carbonyl)]aminopropandiol groups (3'-amine-ON CPG,
Clontech). 2'-O-Methyl nucleoside (2-cyanoethyl)-N,N-diiso-
propylphosphoramidites with the following protecting groups
were used: A: N6-phenoxyacetyl, 5'-O-DMTr; C: N4-benzoyl,
5'-0-MMTr; G: I^-phenoxyacetyl, 5'-O-DMTr; U: 5'-O-
MMTr (13,14). Standard DNA synthesis methodology with
increased coupling time (5 min instead of 3 min) was used. The
ON was deprotected and cleaved from the solid support with 25%
aqueous ammonia (15 hours at 55°C). The crude ON 1 was
purified by ethanol precipitation.
Synthesis of thiocholesterol-modified ONs
a) Modification with dithiopyridine groups: A solution of
14.1 AU26o (about 450 ng; 67 nmol) of a 2'-O-methylated
oligoribonucleotide 19mer 1 with the sequence 5'-CUA AAA
GAG CUG UAA CACU-3' modified with (3-amino-2-hydroxy-
propyl)phosphate at the 3'-end, in 0.75 ml 50 mM HEPES buffer
(pH 7.9) was treated with a solution of 4.2 mg (13.4 /tmol, 200
equivalents) of N-succinimidyl-3-(2-pyridyldithio)propionate
(SPDP, Pharmacia) in 300 /*1 ethanol for 4 hours at room
temperature. The mixture was then subjected to gel filtration on
Sephadex G25 (PD10 column, Pharmacia) with 20 mM HEPES
buffer (pH 7.3) as eluent. The first fractions containing ON were
evaporated to dryness in a Speedvac (Savant), dissolved in 200 /tl
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of water, and further purified by reverse phase HPLC (Nucleosil
RP-18 column, 250x4 mm; buffer A: 100 mM triethyl-
ammonium acetate pH 6.5; buffer B: acetonitrile; gradient: 0-40
min, 0-40% B). This procedure gave 12.2 AU26? ON 2a
(corresponding to 57 nmol, 85% yield, Fig. 1) modified with
about 52 nmol dithiopyridine groups (according to the UV assay
at 343 nm described above).
PMDBD-salt formation: A solution of 8.1 AU26o (about 255 /*g,
37 nmol) of 2a in 250 jtl water was added to 250 pi of a solution
of 4 mg PMDBD (3,3,6,9,9-pentamethyl-2,10-diazabicyclo
[4.4.0]dec-l-ene, = Heinzer base, Fluka, (15)) carbonate salt
in 50% aqueous methanol. The solution was then diluted with
water to a volume of 3 ml and freeze-dried. The lyophylisate
was dissolved in 1 ml of methanol/water (1:4) and subjected to
gel filtration on Sephadex G25 (PD10 column; elution with
methanol/water 1:4). The fractions containing ON (7.1 AU260,
due to absorbance of the nucleotides; 15 AU219, mainly due to
absorbance of ca 0.65 ^mol PMDBD; 88% yield of 2b) were
concentrated in the Speedvac to remove methanol, lyophilized
and then dissolved in 1.0 ml of methanol/dichloromethane (1:2).
Conjugation to thiocholesterol: To half of the solution (0.5 ml,
16 nmol of ON 2b), 200 /tl methanol, 30 iA of 180 mM
methanolic PMDBD trifluoroacetate buffer (pH 9) and 600 /ig
(1.5 jtmol) thiocholesterol (Sigma) in 300 /A dichloromethane
were added. The reaction mixture was kept under argon for 20 h
at room temperature. The solution was evaporated to dry ness
in the Speedvac, dissolved in 400 fil methanol/chloroform (1:1),
and extracted with 8x100 jtl of water. The aqueous extracts
(containing 2.3 AU2go of ON) were combined and concentrated
in the Speedvac to a volume of about 500 fi\ to remove methanol.
Fractionation by reverse phase HPLC (Nucleosil RP-18 column,
250x4 mm; buffer A: 100 mM triethylammonium acetate pH 7;
buffer B: acetonitrile; flow: 1 ml/min; gradient: 0 -50 min,
0-50% B; 50-70 min, 50-100% B) yielded 0.84 AU260
(24%) of ON in cholesterol-free form at a concentration of about
20% acetonitrile, and 1.5 AU260 (42%) of the thiocholesterol-
modified ON 3 at a concentration of 55-68% acetonitrile.
b) In an analogous fashion a 2'-O-methylated oligoribonucleo-
tide 19mer containing an amino-modified 3'-end with the
sequence 5'-GAG CAC ACU UCA UGC AGUG-3' was linked
to thiocholesterol. HPLC purification of the intermediates was
omitted in order to improve the overall yield.
The pyridyldithiopropionate-modified ON was obtained as a
crude product after reaction of the amino-modified ON with 200
equivalents of SPDP and conversion to the PMDBD salt
(12 AU260; about 60 nmol). Reverse phase HPLC analysis (see
Fig. 2) showed that the crude product contained about 75%
dithiopyridine-modified product (eluting at 20% acetonitrile)
contaminated with 25% of non-modified material eluting at 19%
acetonitrile. The crude product was treated with 100 equivalents
of thiocholesterol in a total volume of 2 ml methanol/dichloro-
methane (2:3) containing 5 mM PMDBD trifluoroacetate pH 8.5.
Workup and HPLC purification yielded 4.7 AU26o (about
160 /tg; 39%) of ON in thiocholesterol-free form (eluting at about
20% acetonitrile) and 5.7 AU260 (about 190 fig; 48%) of the
thiocholesteryl-modified form (eluting at 55—68% acetonitrile).
32P-Labeling of modified ONs
Thiocholesteryl-modified 2'-O-methyl-oligoribonucleotide and a
non-modified 2'-O-methyl-oligoribonucleotide as a control were
5'-32P-labeled using an incubation buffer with a minimum
amount of reducing agents. One pmol ON was incubated in 10 ^ 1
buffer [50 mM Tris.HCl pH 7.5, 10 mM MgCl2, 100 mM
NaCl, 1 mM dithioerythritol (DTE)] with 10 units T4
polynucleotide kinase (Boehringer Mannheim) and 2 pmol
7-32P-ATP for 30 min at 37 °C. The labeled ON was then
purified by gel filtration on Sephadex G-25 (1.8 ml bed volume,
50 mM HEPES pH 7.3) after addition of 10 pmol unlabeled ON
to minimize unspecific absorption. The first peak of radioactivity
appearing in the void volume was collected.
Reductive cleavage of thiocholesteryl-modified ONs
A solution of 0.1 AU260 (46 nmol) thiocholesteryl-modified ON
(as prepared in b) in 900 /tl 25 mM HEPES buffer (pH 7.3) was
brought to a concentration of 10 mM dithiothreitol by addition
of 1.4 mg DTT and kept under argon at 37°C for 18 h. Analysis
by reverse phase HPLC under the same conditions described
above showed complete cleavage of the thiocholesteryl-modified
ON. A similar experiment was performed with /3-mercaptoethanol
(BME) as reducing agent and resulted in the same cleavage
product, which eluted at a gradient concentration of about 18%
acetonitrile (Fig. 2, lane 4). The other earlier eluting peaks derive
from the reducing agent.
Incorporation of thiocholesteryl-modified 2'-O-methyl-
oligoribonucleotides into liposomes
Liposotne preparation: Liposomes were prepared by the REV
(reverse-phase evaporation) method (16,17). The aqueous phase
consisted of 175 n\ 50 mM HEPES (pH 7.3), 1 mM calcein and
1 fiM 2'-OMe-RNA (thiocholesteryl-modified or unmodified as
control), spiked with a trace amount of 5'-32P-labeled material.
The organic phase was a solution of 5 /tmol L-a-lecithin (from
egg yolk, mainly palmitoyl-oleoylphosphatidylcholine; Avanti
Polar Lipids) in 600 jil diethylether (extracted with 50 mM
HEPES buffer). The two phases were thoroughly mixed in a glass
tube by vortexing and sonicated 5 min at 0°C in a bath-type
sonicator. The resulting stable emulsion was slowly evaporated
on a rotary evaporator with occasional vortexing. After complete
removal of the diethylether (30 min at 200 mbar) the liposome
3—o** ^O^*V^^"N
PySSProfwxiate-NHS eser
(SPDP) pH 7.8
^OMs-Cftgo^^^>o^ l^ld l^o i^d«
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Figure 1. Synthesis of thiocholesteryl-modified oligonucleotides.
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solution was then further sonicated for 20 min at 0°C. The
resulting solution was diluted with 175 pi 50 mM HEPES pH 7.3
and stored at 2°C.
Gel filtration of liposomes: The liposomes (an aliquot of 200 pi)
were separated from unincorporated material by gel filtration on
Sephadex G-75 Superfine (10 ml bed volume, 50 mM HEPES
pH 7.3). Fractions of 600 pi were collected and subjected to UV
analysis and Cerenkov counting. The calcein absorbance
(493 nm) was corrected for the unspecific absorbance of the
liposomes measured at 600 nm. As a control an aliquot of labeled
ON not coupled to thiocholesterol was subjected to gel filtration
under the same conditions. The efficiency of encapsulation of
the aqueous phase was calculated from the calcein absorbance
associated with the liposome fractions (2.5-4.5 ml, see Fig. 3)
and the non-incorporated calcein eluting with the low molecular
weight fractions (7-14 ml). In the case of the unmodified ON
incorporation efficiency was determined by comparing the
radioactivity in the liposome fractions (2.5-4.5 ml) with the total
eluted radioactivity. Because of some degradation of the label
during liposome preparation in the presence of thiocholesteryl-
modified ON, the liposome-incorporated radioactivity
(2.5—4.5 ml) was compared to the radioactivity in the high
molecular weight fractions only (2.5-9.0 ml; see Fig. 3a). The
value of the liposome-associated radioactivity was corrected for
the amount of low molecular weight 32P from orthophosphate
and/or nucleotides in the liposomes due to simple volume
inclusion.
Binding of ONs to liposomes or to cultured cells
Liposomes were prepared by REV from an aqueous phase
containing 10 mM HEPES pH 7.3, 150 mM NaCl and 100 mM
calcein. After purification by gel filtration using HEPES/NaCl
buffer, 200 pi of liposomes was mixed with 32P-labeled
thiocholesteryl-modified 2'-OMe-RNA (0.5 pM). After agitating
for 10 min the solution was analyzed by gel filtration on Sephadex
G-75 Medium (Pharmacia, 13 ml bed volume) as described
above.
The mouse embryonic liver cell line ATCC TIB 73 (BNL CL.2
(18)) was grown at 37°C in 5% CO2 in high glucose DMEM
(0.45% glucose) supplemented with 10% heat-deactivated FCS.
For binding studies the cells were seeded into 24-well plates (1.5
3'-NH2 ON 1
SPDP-ON 2a
Chol-SS-ON 3
BME cleavage
10 20 30
min
40 50 60
Figure 2. Reverse phase HPLC analysis of modified oligonucleotides on a
Nucleosil RP-18 column (250x4 mm; buffer A: 100 mM triethylammonium
acetate pH 6.5; buffer B: acetonitrile; gradient: 0 -40 min, 0-50% B;
40-60 min, 50-100% B). Lane 1: 3'-amino modified 2'-OMe-RNA 1 (3'-NH2
ON); lane 2: SPDP modified 2'-OMe-RNA 2a (SPDP-ON); lane 3: thiocholesteryl
coupled 2'-OMe-RNA 3 (ChoI-SS-ON); lane 4: cleavage of ON 3 with BME
(see Materials and Methods).
cm diameter). After growing to a density of 1.2 X105 cells/well
(30% confluency) 250 pi of fresh medium supplemented with
0.5 pM 32P-labeled thiocholesteryl-modified 2'-OMe-RNA or
unmodified 2'-0Me-RNA was added. At the indicated times the
medium was removed and the cells were washed 3 times with
2 ml PBS and finally with 250 pi serum-containing medium.
Then the cell layer was lysed with 250 pi proteinase K lysis buffer
(0.1 pg/pl proteinase K, 0.5% SDS, 150 mM NaCl, 20 mM
HEPES, pH 7.4) and counted (Fig. S).
HPLC analysis of cell-associated and internalized oligonucleo-
tides: After a 5 h treatment of TIB 73 cells with 0.5 pM 32P-
labeled thiocholesteryl-modified 2'-OMe-RNA in serum-free
medium as described above, the cells were washed and lysed
with 250 pi 1 % SDS in PBS. The DNA was sheared by a short
sonification and the diluted extract (ca. 5-fold, PBS) was filtered
through a Centricon centrifugal microconcentrator (10 000 MW
cutoff, Amicon) to remove membranes, proteins and cellular
nucleic acids. During this procedure the thiocholesteryl-modified
ONs were retained due to adsorption to the membrane and/or
the retained cellular components. An aliquot of the flow-through
was subjected to reverse phase HPLC. The collected fractions
(4 ml) were analyzed by scintillation counting (Fig. 6).
Reversed phase C-18 cartridge analysis of oligonucleotides: To
measure the amount of thiocholesteryl-modified ONs in cell
extracts, 250 pi of medium containing 10% FCS, 200 pi 100 mM
triethylammonium acetate pH 6.5 and 300 pi acetonitrile were
added to 250 pi of extract made in proteinase K lysis buffer. The
a) so
Figure 3. Incorporation of oligonucleotides into liposomes: Liposomes prepared
with thiocholesteryl-modified 2'-OMe-RNA (a) or with unmodified 2'-OMe-RNA
(b) were subjected to gel filtration on Sephadex G-75 as described under Materials
and Methods. [Open circles: calcein absorbance at 493 nm (% of total eluted
absorbance); filled circles: cpm of 32P (% of total eluted radioactivity)],
c) Incorporation efficiencies of thiocholesteryl-modified ONs and unmodified ONs
compared to the inclusion of fluid-phase marker (calcein). Values were calculated
from the data in Fig. 3a and 3b as described under Materials and Methods.
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mixture was passed through a C-18 cartridge (Sep-Pack, Waters)
which was pretreated with 30% acetonitrile in 100 mM
triethylammonium acetate pH 6.5 and the flow-through was
collected. The cartridge was washed with 2 ml of the same buffer
and the combined solutions, which would contain unmodified
2'-OMe-RNA and free phosphate, were counted for 32P. The
adsorbed radioactivity representing thiocholesteryl-modified ON
was detected by counting the packing material. Analysis of the
ONs in the conditioned medium was performed analogously after
adjusting the total protein and lipid content by adding 250 /*1 of
extract from untreated control cells to 250 /tl of conditioned
medium. For calibration the same analysis was performed after
mixing thiocholesteryl-modified and unmodified 2'-0Me-RNA
with control cell extract and medium (76% resp. 2% retention
on the cartridge).
RESULTS
Synthesis of tMocholesteryl-modified 2'-O-methyl-
oligoribonucleotides
The conjugation of modified 2'-O-methyl-oligoribonucleotides
with thiocholesterol was accomplished as shown in Fig. 1 through
ligation via disulfide bond formation. Reaction of ON 1, modified
with a (3-amino-2-hydroxypropyl)phosphate group at the 3'-end,
with an excess of SPDP, and subsequent isolation by gel filtration
and reverse phase HPLC yielded the pyridyldithiopropionate-
modified compound 2a. To enable the coupling to thiocholesterol,
a compound which has very limited solubility in polar solvents
a) 300
Figure 4. Alkaline phosphatase digest: An aliquot (400 /d) of liposomes containing
thiocholesteryl-modified ON from the Sephadex G-75 column in Fig. 3a (fraction
2.5-4.5 ml, in 50 mM HEPES pH 7.3) was treated with 5 units of calf intestine
alkaline phosphatase (Boehringer Mannheim) for 2 h at 37°C (a). As a control
the same amount of liposomes was treated with 5 units alkaline phosphatase in
the presence of 1 y\ Triton X-100 for 1 h at 37°C (b). The digests were subjected
to gel filtration on Sephadex G-25 PD-10 columns and 800 jd fractions were
analyzed by UV absorption and Cerenkov counting. [Open circles: calcein
absorbance at 493 nm; filled circles: 32P (cpm)]. c) A cartoon consistent with
the finding that most, if not all thiocholesteryl-modified ONs are incorporated
into the phospholipid-bilayer.
like water or methanol, the ON was converted to the lipophilic
PMDBD salt. PMDBD, a highly methylated bicyclic amidinium
base developed by the group of A. Eschenmoser (15), has been
reported to solubilize sulfate and phosphate ions in apolar solvents
such as dichloromethane. The ON-PMDBD salt 2b was readily
soluble in dichloromethane/methanol (2:1). The ligation with
thiocholesterol via disulfide bond formation occurred in the
presence of 5 mM PMDBD trifluoroacetate buffer (pH 9);
workup and purification by HPLC gave the desired
thiocholesteryl-modified ON 3.
The increased lipophilicity of the conjugate is indicated by its
behavior during reverse phase HPLC (Fig. 2). Conjugate 3 eluted
at ca. 60% acetonitrile (lane 3), compared to ca 20% acetonitrile
for unconjugated ONs (lanes 1 and 2). As a consequence of the
disulfide group within the conjugate, the ON moiety could be
released from the lipophilic anchor by treatment with reducing
agents such as dithiothreitol or BME (Fig. 2 lane 4).
Incorporation of thiocholesteryl-modified ONs into liposomes
Liposomes were prepared by the reverse-phase evaporation
method (16) in the presence of 1 mM calcein as a low molecular
weight fluid phase marker and 1 /*M 5'-32P-labeled
thiocholesteryl-modified or unmodified ONs. Separation from
unincorporated material was performed by gel filtration (see
Fig. 3). In the case of unmodified 2'-OMe-RNA, 10-15% of
both calcein and ON were encapsulated into liposomes and eluted
in fractions 2.5-4.5 ml (Fig. 3b). Most of the 32P appeared as
free ON in fractions 4.5-7.5 ml. By contrast, incorporation of
thiocholesteryl-modified ONs into the liposome fractions was
much higher (65%). Only a small fraction of free ON, eluting
as a broad peak due to unspecific absorption to the
chromatographic support, in combination with small amounts of
free, unincorporated phophate was seen (Fig. 3a). These results
cannot be explained by a mechanism of pure fluid phase
encapsulation, as only 10—15% of the calcein was incorporated
into the same liposomes (Fig. 3c). Liposomes containing these
lipid-modified ONs were subjected to alkaline phosphatase
treatment and a further gel filtration (Fig. 4). The 32P label of
approximately half of the membrane-associated ON was removed
and eluted as 32P-phosphate in fractions 7 -12 (Fig. 4a). This
0 25 0.25 5 24
tlTO(h)
Figure 5. Time course of association of thiocholesteryl-modified 2'-O-methyl-
RNA (dashed bars) or unmodified 2'-O-methyl-RNA (dark bars) with TIB 73
cells in the absence (left panel) or presence (right panel) of serum. TIB 73 cells
were incubated with 32P-labeled thiocholesteryl-modified or unmodified 2'-OMe-
RNA. At the indicated times the medium was removed, cells were washed and
the radioactivity in the lysates was counted (see Materials and Methods). During
the course of the experiment (48 h) the cells grew from 30% to 100% confluency.
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is consistent with the explanation that half of the ON is inserted
into the outside of the liposomal membrane (Fig. 4c). Alkaline
phosphatase treatment was also done in the presence of Triton
X-100, which causes liposome breakdown (Fig. 4b). All of the
radioactivity appeared in the phosphate fractions 7-12, indicating
that all the ONs are accessible and dephosphorylated by the
phosphatase under these conditions. Calcein was also released
from the liposomes and eluted as a broad peak in the low
molecular weight fractions 7 -19 (Fig. 4b).
Binding off tWodiolesteryl-modified ONs to liposomes and to
cultured cells
When ONs were incubated with preformed liposomes or with
cultured cells, the thiocholesterol modification resulted in highly
increased binding. Upon addition to liposomes almost all of the
modified ONs eluted in the liposome fraction of a gel filtration
column, whereas in the absence of liposomes the ONs nearly
quantitatively adhered to the column material under these elution
buffer conditions (data not shown). In cell culture with the mouse
embryonic liver cell line TIB73 in serum-free medium, 14% of
the modified ON was rapidly adsorbed by the cell layer after
15 min (Fig. 5). In a control experiment only 0.15% of an
unmodified 2'-OMe-RNA was adsorbed. Similar findings of
enhanced association of thiocholesteryl-ON conjugates have also
been found with HL60 or HepG2 cells (data not shown).
The serum content in the tissue culture medium had a striking
effect on the association of ONs with cells (see Fig. 5). The
presence of 10% fetal calf serum significantly reduced the initial
binding of thiocholesteryl-ON conjugates to only 0.9% after a
15 min incubation (compared to 0.07% with the control 2'-OMe-
RNA). A longer incubation time, however, resulted in increased
association with cells that reached a value of 11 % after 48 h
(compared to 1% with the control 2'-OMe-RNA). Correction
of the values for the increasing cell number during the course
of the experiment reveals a 3-fold increase in binding during the
first 5 h, and thereafter the values remain constant.
To distinguish internalized from cell-surface bound ONs, cells
were analyzed by treatment with alkaline phosphatase. In a control
Table 1. Ratio of internalized to surface-bound ONs.
a
b
c
d
e
CHOL-ON
fixed cells
CHOL-ON
CHOL-ON
control-ON
CHOL-ON
serum
(%)
0
0
0
0
10
time
5 min
15 min
5 h
5 h
5 h
32P.o.(%)
6.0
7.6
18.7
1.3
4.5
32Pint
(%)
0.2
1.3
7.1
0.9
1.7
32Pim
32Pto.
0.03
0.17
0.38
0.69
0.38
Thiocholesteryl-modified 2'-OMe-RNA (a-c, e) or 2'-OMe-RNA (d), 32P-labeled
at the 5'-end, was incubated with TIB 73 cells in serum-free medium (a-d) or
in medium containing 10% FCS (e) as described in Material and Methods. In
a control experiment (a) the cells were fixed with glutaraldehyde prior to incubation
(1.2% in PBS, 10 min, 25°C; inactivation of excess aldehyde groups with 100 mM
glycine pH 7.7, 150 mM NaCl, 1 h, 37°C). After removing the medium and
thoroughly washing with PBS, the cells were treated 3 times with 10 units alkaline
phosphatase in 250 /JI HBS (supplemented with 20 mM NaN3) for 30 min at
37°C. The individual supematants were collected and counted after removal of
some detached cells by centrifugation. The remaining cells together with the
detached cells were lysed with proteinase K lysis buffer and counted as described
in Materials and Methods (32PtoI> total cell-associated radioactivity in % of total
amount added to the cells; 32PjM, radioactivity which is not removed by alkaline
phosphatase treatment).
experiment, where endocytosis was prevented by pretreating the
cells with glutaraldehyde, 97% of the cell-bound radioactivity
could be removed (Table 1). During incubation of living TIB 73
cells with thiocholesteryl-modified ON, the fraction of internal,
phosphatase-inaccessible ON increased from an initial 17%
(15 min) to 38% (5 h) of cell-bound ONs . After 5 h incubation
in serum-free medium with either cholesteryl-modified or
unmodified 2'-OMe-RNA, there was 15-fold higher binding
(18.7% vs. 1.3% of total radioactivity) and 8-fold higher
internalization (7.1% vs. 0.9%) of the thiocholesteryl-modified
compound.
Cleavage off the oMgonucIeotides
To determine the fate of the thiocholesteryl-modified ONs
associated with cells, TIB 73 cell lysates were subjected to
analysis on a C-18 cartridge after 7 h and 24 h of incubation.
The amount of lipophilic-modified ONs, which was calculated
as the percentage of 32P that bound to the cartridge (see
Materials and Methods), was 51 % at 7 h and decreased to 25%
at 24 h. These results could be due to reductive cleavage of the
thiocholesteryl moiety and/or to dephosphorylation of the ON
by phosphatases. To distinguish between these two possibilities
a reverse phase HPLC analysis of cell-associated radioactivity
was performed using extracts of TIB 73 cells that had been
incubated with thiocholesteryl-modified ON for 5 h in serum-
free medium. After removal of thiocholesteryl-modified ONs
together with membranes and other macromolecular cellular
components by ultrafiltration, HPLC analysis (Fig. 6) of the
soluble fraction revealed that 48% of the radioactivity eluted at
a position corresponding to orthophosphate and/or nucleotides
and 52% eluted in the thiocholesterol-free ON fraction at
2 0 - 3 5 % acetonitrile. Thus, loss of 32P end-labeled
thiocholesteryl-modified ON is due to reduction of the disulfide
bond and release of the free ON into the cell as well as to the
action of phosphatases to the same extent.
DISCUSSION
A lipophilic anchor attached to ONs facilitates their uptake into
cells (7), but such ONs may remain trapped in membranes.
Furthermore, modification with lipid may result in unspecific (not
sequence-specific) side effects (7,19). To obtain a potentially
bioreversible linkage of lipid to ONs, 2'-O-methyl-
nudeotides
or phosphate
[cpml
0 5 15 25 35 45 55 65 75 65
* acetonltrilc
Figure 6. HPLC analysis of 32P-labeled thiocholesteryl-modified ON 3 on a
Nucleosil RP-18 column (250x4 mm; buffer A: 100 mM triethylammonium
acetate pH 6.5; buffer B: acetonitrile; flow: 0.8 ml/min; gradient: 0 - 5 0 min,
0-100% B; the sample was injected in buffer containing 50% ethanol) (a).
Analysis of the soluble fraction of a TIB 73 cell extract (obtained by ultrafiltration)
after 5 h incubation with thiocholesteryl-modified ON (b).
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oligoribonucleotides modified with an amino-linker at the 3'-end
were coupled to thiocholesterol via a disulfide bond. The key
step of the synthesis was conversion of the ON to the 'Heinzer
base' salt (15) which we found was soluble in dichloromethane
containing small amounts of methanol . This allowed reaction
of the ON with thiocholesterol in homogeneous solution using
an apolar nonaqueous solvent system. 2'-O-Methyl-
oligoribonucleotides were used in the present study, as such
analogues are resistant to a variety of DNases and RNases (20).
These compounds were found to be about 300 times more
effective than antisense oligodeoxynucleotides in an in vitro
antisense inhibition assay (14).
Upon liposome formation in the presence of thiocholesteryl-
modified ONs a highly efficient loading of liposomes with the
ONs was observed (Fig. 3c). The incorporation was about six
times higher than the fluid-phase encapsulation of corresponding
thiocholesteryl-free ONs. The lipid-modified ONs seem to be
incorporated into the liposome membranes both on the inside and
outside. This was supported by our finding that the phosphate
label of half the ONs, i.e. those which presumably were exposed
on the outer surface of the liposomes, could be removed by
treatment with alkaline phosphatase. In addition to the high
incorporation efficiency these new ON-bearing liposomes may
be interesting candidates for the delivery of antisense compounds
into cells.
In comparison to unmodified 2'-0Me-RNA, the
thiocholesteryl-rnodified ONs showed a strongly enhanced affinity
both for preformed liposomes and cultured cells. In the presence
of serum, cell association was initially reduced, presumably
resulting from absorption of the ON to serum proteins; for
example, cholesteryl-modified ONs bind to lipoproteins (our
unpublished results). Upon further incubation, there is a
significant increase in cell association of lipid-modified ONs
(Fig. 5). This serum effect is not due to a rapid cleavage of the
ON from the thiocholesteryl moiety by serum components:
reverse phase HPLC analysis of the cell culture medium after
5 h of incubation showed that about 80% of the 5'-32P-labeled
ONs still contain the thiocholesteryl moiety (data not shown).
A large fraction of the cell-associated oligonucleotides is
internalized as shown by protection from alkaline phosphatase
digestion (Table 1).
We have demonstrated that the thiocholesteryl moiety is
released from the ON conjugate under mild reducing conditions
such as treatment with DTT in vitro. The cleavage of disulfide
bonds in macromolecule conjugates upon endocytosis into
cultured cells has been reported (12). A similar reductive
processing also occurs with thiocholesteryl-rnodified ONs in cells.
We were able to detect considerable amounts of thiocholesteryl-
free ONs in a cellular extract (Fig. 6) which is consistent with
cleavage of the disulfide bond. This release of the ONs from the
membrane-bound lipophilic anchor may be beneficial for the
interaction of the ONs with their cellular targets when applying
these compounds as antisense reagents.
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